Nicholas Company Inc. Holds Stake in Danaher Corporation (NYSE:DHR)

Nicholas Company Inc. held its position in shares of Danaher Corporation (NYSE:DHR) during the first quarter, Holdings Channel reports. The firm owned 90,530 shares of the conglomerate’s stock at the end of the first quarter. Nicholas Company Inc.’s holdings in Danaher Corporation were worth $7,743,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after buying an additional 1,530,015 shares in the last quarter. FMR LLC increased its position in shares of Danaher Corporation by 0.3% in the first quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock valued at $1,662,803,000 after buying an additional 53,429 shares in the last quarter. Parnassus Investments CA increased its position in shares of Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock valued at $712,738,000 after buying an additional 1,143,284 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Danaher Corporation by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock valued at $653,946,000 after buying an additional 50,673 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Danaher Corporation by 6.0% in the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock valued at $496,687,000 after buying an additional 329,458 shares in the last quarter. 76.56% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher Corporation (NYSE DHR) traded down 0.41% during midday trading on Tuesday, reaching $81.10. 309,239 shares of the company traded hands. The stock has a 50 day moving average price of $83.93 and a 200 day moving average price of $84.29. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The firm has a market capitalization of $56.34 billion, a PE ratio of 25.89 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 EPS. Analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.themarketsdaily.com/2017/08/08/nicholas-company-inc-holds-stake-in-danaher-corporation-nysedhr.html.

Several equities analysts have weighed in on DHR shares. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. BTIG Research reaffirmed a “buy” rating and set a $92.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $88.00 price target (down previously from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. BidaskClub raised shares of Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $91.76.

In other news, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock worth $3,206,426 in the last 90 days. 12.20% of the stock is currently owned by insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply